Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.124.038783 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Naureen Qadri und 15 weiteren Autor:innen. Beteiligte Einrichtung: Minneapolis Heart Institute Foundation Minneapolis MN USA. Hauptthemen laut MEDLINE: Furosemide, Heart Failure, Sodium Potassium Chloride Symporter Inhibitors. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Little is known about the initial dosing of loop diuretics among patients hospitalized for heart failure and its association with outcomes.
Methods
We identified patients admitted for heart failure at 24 hospitals across two health systems between January 1, 2017, and December 31, 2020. Initial diuretic dose was categorized relative to home dose in furosemide equivalents. The primary outcomes (length of stay) and secondary outcomes (rates of acute kidney injury, in‐hospital mortality, and 30‐day readmissions) were compared across categories of initial diuretic dose.
Results
Among 14 332 patients admitted for heart failure, the initial diuretic dose was lower‐than‐home dose in 1866 (13.0%) patients, equivalent‐to‐home dose in 3171 (22.1%) patients, and higher‐than‐home dose in 9295 (64.9%) patients. Compared with patients who received an equivalent or higher initial diuretic dose relative to home dose, risk‐adjusted length of stay was longer among patients receiving a lower dose (4.9 days versus 4.0 days versus 4.0 days, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Minneapolis Heart Institute Foundation Minneapolis MN USA.
- Health Catalyst Minneapolis MN USA.
- Atrium Health Charlotte NC USA.
- Department of Medicine, Division of Cardiology Emory University School of Medicine Atlanta GA USA.
- Department of Cardiology, Smidt Heart Institute Cedars-Sinai Medical Center Los Angeles CA USA.
- Center for Cardiovascular Analytics, Research, and Data Science (CARDS) Providence Heart Institute Portland OR USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Qadri, N., Kwok, E., Stanberry, L., Thomas, C., Irausquin, S. J., Gupta, D., Ebinger, J. E., Gluckman, T. J., Mutharasan, R. K., Goyal, A., Brownell, N. K., Scirica, B. M., Ho, P. M., Das, S. R., Downey, W., & Bradley, S. M. (2026). Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038783
Vancouver
Qadri N, Kwok E, Stanberry L, Thomas C, Irausquin SJ, Gupta D, et al. Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium. Journal of the American Heart Association. 2026. doi:10.1161/jaha.124.038783
BibTeX
@article{Qadri2026,
author = {Qadri, Naureen and Kwok, Erica and Stanberry, Larissa and Thomas, Chelsey and Irausquin, Stephanie J and Gupta, Divya and Ebinger, Joseph E and Gluckman, Ty J and Mutharasan, R Kannan and Goyal, Abhinav and Brownell, Nicholas K and Scirica, Benjamin M and Ho, P Michael and Das, Sandeep R and Downey, William and Bradley, Steven M},
title = {Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.124.038783}
}
EUVIMED